title: Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM.
authors.forename: Liliana
authors.initials: L
authors.lastname: Devizzi
authors.forename: Anna
authors.initials: A
authors.lastname: Guidetti
authors.forename: Ettore
authors.initials: E
authors.lastname: Seregni
authors.forename: Roberto
authors.initials: R
authors.lastname: Passera
authors.forename: Marco
authors.initials: M
authors.lastname: Maccauro
authors.forename: Michele
authors.initials: M
authors.lastname: Magni
authors.forename: Adele
authors.initials: A
authors.lastname: Testi
authors.forename: Massimo
authors.initials: M
authors.lastname: Di Nicola
authors.forename: Corrado
authors.initials: C
authors.lastname: Tarella
authors.forename: Paola
authors.initials: P
authors.lastname: Matteucci
authors.forename: Simonetta
authors.initials: S
authors.lastname: Viviani
authors.forename: Marco
authors.initials: M
authors.lastname: Ruella
authors.forename: Carmelo
authors.initials: C
authors.lastname: Carlo-Stella
authors.forename: Carlo
authors.initials: C
authors.lastname: Chiesa
authors.forename: Maria Cristina
authors.initials: MC
authors.lastname: Cox
authors.forename: Emilio
authors.initials: E
authors.lastname: Bombardieri
authors.forename: Alessandro M
authors.initials: AM
authors.lastname: Gianni
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects; D018572:Disease-Free Survival; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D053208:Kaplan-Meier Estimate; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology / Q000628:therapy*; D016499:Radioimmunotherapy / Q000009:adverse effects / Q000379:methods*; D019275:Radiopharmaceuticals / Q000008:administration & dosage / Q000009:adverse effects; D012307:Risk Factors; D014182:Transplantation, Autologous; D015021:Yttrium Radioisotopes / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000911:Antibodies, Monoclonal; D019275:Radiopharmaceuticals; D015021:Yttrium Radioisotopes; C422802:ibritumomab tiuxetan